111 related articles for article (PubMed ID: 38737930)
1. Evaluation strategy of anti-mitochondrial antibodies M2-negative: the role of multiplex rodent tissues and related clinical implications.
Tolassi C; Assandri R
Gastroenterol Hepatol Bed Bench; 2024; 17(1):1-7. PubMed ID: 38737930
[TBL] [Abstract][Full Text] [Related]
2. Anti-DFS70 antibodies detected by immunoblot methods: A reliable tool to confirm the dense fine speckles ANA pattern.
Bizzaro N; Pesente F; Cucchiaro F; Infantino M; Tampoia M; Villalta D; Fabris M; Tonutti E
J Immunol Methods; 2016 Sep; 436():50-3. PubMed ID: 27374867
[TBL] [Abstract][Full Text] [Related]
3. [Modern look at the problems of investigation of antinuclear antibodies in systemic lupus erythematosus (literature review).].
Aleksandrova EN; Verizhnikova ZG; Novikov AA; Lukina GV
Klin Lab Diagn; 2018; 63(6):340-348. PubMed ID: 30702224
[TBL] [Abstract][Full Text] [Related]
4. Overcoming a "probable" diagnosis in antimitochondrial antibody negative primary biliary cirrhosis: study of 100 sera and review of the literature.
Bizzaro N; Covini G; Rosina F; Muratori P; Tonutti E; Villalta D; Pesente F; Alessio MG; Tampoia M; Antico A; Platzgummer S; Porcelli B; Terzuoli L; Liguori M; Bassetti D; Brusca I; Almasio PL; Tarantino G; Bonaguri C; Agostinis P; Bredi E; Tozzoli R; Invernizzi P; Selmi C
Clin Rev Allergy Immunol; 2012 Jun; 42(3):288-97. PubMed ID: 21188646
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic relevance and clinical significance of the new enhanced performance M2 (MIT3) ELISA for the detection of IgA and IgG antimitochondrial antibodies in primary biliary cirrhosis.
Gabeta S; Norman GL; Liaskos C; Papamichalis PA; Zografos T; Garagounis A; Rigopoulou EI; Dalekos GN
J Clin Immunol; 2007 Jul; 27(4):378-87. PubMed ID: 17514501
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic value of screening methods for the determination of antinuclear antibodies using indirect immunofluorescence on HEp-2 cells and enzyme immunoassay in autoimmune liver diseases.
Dorofeev AS; Aleksandrova EN; Novikov AA; Saliev KG; Sandler YG; Vinnitskaya EV
Klin Lab Diagn; 2022 Nov; 67(11):652-657. PubMed ID: 36398774
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic accuracy of ELISA methods as an alternative screening test to indirect immunofluorescence for the detection of antinuclear antibodies. Evaluation of five commercial kits.
Tonuttia E; Bassetti D; Piazza A; Visentini D; Poletto M; Bassetto F; Caciagli P; Villalta D; Tozzoli R; Bizzaro N
Autoimmunity; 2004 Mar; 37(2):171-6. PubMed ID: 15293886
[TBL] [Abstract][Full Text] [Related]
8. Correlation of antinuclear antibody immunofluorescence patterns with immune profile using line immunoassay in the Indian scenario.
Sebastian W; Roy A; Kini U; Mullick S
Indian J Pathol Microbiol; 2010; 53(3):427-32. PubMed ID: 20699497
[TBL] [Abstract][Full Text] [Related]
9. Specific chemoluminescence and immunoasdorption tests for anti-DFS70 antibodies avoid false positive results by indirect immunofluorescence.
Bizzaro N; Tonutti E; Tampoia M; Infantino M; Cucchiaro F; Pesente F; Morozzi G; Fabris M; Villalta D;
Clin Chim Acta; 2015 Dec; 451(Pt B):271-7. PubMed ID: 26471835
[TBL] [Abstract][Full Text] [Related]
10. Association of Immunofluorescence pattern of Antinuclear Antibody with Specific Autoantibodies in the Bangladeshi Population.
Sharmin S; Ahmed S; Abu Saleh A; Rahman F; Choudhury MR; Hassan MM
Bangladesh Med Res Counc Bull; 2014 Aug; 40(2):74-8. PubMed ID: 26415344
[TBL] [Abstract][Full Text] [Related]
11. [Investigation of the diagnostic value of anti-dense fine speckled 70/lens epithelium derived growth factor p75 autoantibody for autoimmune diseases].
Türkoğlu G; Berkem R; Karakoç AE
Mikrobiyol Bul; 2018 Oct; 52(4):413-424. PubMed ID: 30522426
[TBL] [Abstract][Full Text] [Related]
12. Anti-SS-A/Ro antibody determination by indirect immunofluorescence and comparison of different methods of anti-nuclear antibody screening: evaluation of the utility of HEp-2 cells transfected with the 60 kDa SS-A/Ro as a substrate.
Tanaka N; Muro Y; Sugiura K; Tomita Y
Mod Rheumatol; 2008; 18(6):585-92. PubMed ID: 18633690
[TBL] [Abstract][Full Text] [Related]
13. Clinical value of anti-DFS70 antibodies in a cohort of patients undergoing routine antinuclear antibodies testing.
Yumuk Z; Demir M
J Immunol Methods; 2020 May; 480():112754. PubMed ID: 32057435
[TBL] [Abstract][Full Text] [Related]
14. Reflex testing of speckled cytoplasmic patterns observed in routine ANA HEp-2 indirect immunofluorescence with a multiplex anti-synthetase dot-blot assay: a multicentric pilot study.
Infantino M; Palterer B; Biagiotti R; Almerigogna F; Benucci M; Damiani A; Grossi V; Azzurri A; Casprini P; Bacci G; Giudizi MG; Manfredi M
Immunol Res; 2018 Feb; 66(1):74-78. PubMed ID: 29159696
[TBL] [Abstract][Full Text] [Related]
15. New genetically engineered DFS70 knock-out HEp-2 cells enable rapid and specific recognition of anti-DFS70 antibodies.
Bizzaro N; Fabris M
Autoimmunity; 2018 Jun; 51(4):152-156. PubMed ID: 29732925
[TBL] [Abstract][Full Text] [Related]
16. Antigen Reactivity and Clinical Significance of Autoantibodies Directed Against the Pyruvate Dehydrogenase Antigen Complex in Patients With Connective Tissue Disease.
Ceribelli A; Isailovic N; Gorlino C; Assandri R; Vecellio M; De Santis M; Satoh M; Selmi C
Front Immunol; 2022; 13():822996. PubMed ID: 35296099
[TBL] [Abstract][Full Text] [Related]
17. Clinical relevance of combined anti-mitochondrial M2 detection assays for primary biliary cirrhosis.
Han E; Jo SJ; Lee H; Choi AR; Lim J; Jung ES; Oh EJ
Clin Chim Acta; 2017 Jan; 464():113-117. PubMed ID: 27864100
[TBL] [Abstract][Full Text] [Related]
18. [Investigation of the Contribution of Autoantibodies to Clinical Diagnosis in Liver Pathologies and the Identification of Accompanying Autoimmune Diseases].
Duran A; Çetin Duran A; Taşkıran İ
Mikrobiyol Bul; 2022 Jan; 56(1):81-94. PubMed ID: 35088962
[TBL] [Abstract][Full Text] [Related]
19. A hierarchical bivariate meta-analysis of diagnostic test accuracy to provide direct comparisons of immunoassays vs. indirect immunofluorescence for initial screening of connective tissue diseases.
Orme ME; Andalucia C; Sjölander S; Bossuyt X
Clin Chem Lab Med; 2021 Feb; 59(3):547-561. PubMed ID: 32352399
[TBL] [Abstract][Full Text] [Related]
20. Negative ANA-IIF in SLE patients: what is beyond?
Abozaid HSM; Hefny HM; Abualfadl EM; Ismail MA; Noreldin AK; Eldin ANN; Goda AM; Ali AH
Clin Rheumatol; 2023 Jul; 42(7):1819-1826. PubMed ID: 37016193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
